AMETEK Q2 2026 earnings: 15% sales growth supports higher guidance

AMETEK (NYSE: AME) reported Q2 2026 revenue of $2.04 billion, up 15% year over year, while GAAP diluted EPS increased to $1.77 from $1.55 and adjusted EPS rose 17% to $2.09. Adjusted operating margins expanded, operating cash flow increased 35%, and both business groups posted double-digit sales growth. The company also raised its full-year adjusted EPS guidance after orders grew 28% during the quarter.

Core earnings results

Revenue growth reflected a combination of organic expansion and contributions from recent acquisitions. Adjusted operating income grew faster than sales, although acquisition-related costs caused GAAP and adjusted margin trends to diverge.

Cash generation also outpaced earnings growth. Free cash flow reached $451.7 million and represented 111% of net income, compared with 92% in the prior-year quarter.

Business and segment performance

Electronic Instruments Group, or EIG, remained the larger segment. Sales increased 14% to $1.32 billion, with growth balanced between organic demand and recent acquisitions. Management highlighted orders from semiconductor and commercial aerospace customers.

EIG’s GAAP operating income increased approximately 7% to $369.7 million, while adjusted operating income rose 12% to $384.7 million. Its adjusted operating margin declined to 29.1% from 29.7%, but the core adjusted margin—which excludes the dilutive effects of recent acquisitions and foreign exchange—improved 40 basis points to 30.1%.

Electromechanical Group, or EMG, recorded the stronger profit expansion. Sales rose 17% to $723.2 million, while adjusted operating income increased 32% to $190.5 million. Its adjusted operating margin reached 26.3%, compared with 23.3% a year earlier, and its core margin expanded 290 basis points. Management attributed the performance to organic sales growth and cited broad order strength in medtech, defense, and automation markets.

Acquisition costs obscure stronger core margins

AMETEK’s GAAP operating margin slipped 20 basis points to 25.8%, even as its adjusted operating margin rose 60 basis points to 26.6%. The difference included $16.2 million of acquisition-related operating costs. After also accounting for acquisition and foreign-exchange dilution, the company’s core adjusted operating margin increased 110 basis points to 27.1%.

Acquisition financing also affected results below operating income. GAAP interest expense increased to $30.1 million from $16.9 million, including $10.0 million of one-time Indicor bridge financing fees. Adjusted interest expense was $20.1 million. The total difference between GAAP and adjusted EPS was $0.32, reflecting acquisition-related intangible amortization, financing fees, and integration costs on an after-tax basis.

Cash flow and balance sheet

Operating cash flow rose to $483.7 million, and capital expenditures were $32.0 million, producing $451.7 million of free cash flow. The 111% free-cash-flow conversion rate indicates that cash generation exceeded reported net income during the quarter.

At June 30, 2026, AMETEK held $495.4 million in cash and cash equivalents, up from $458.0 million at the end of 2025. Short-term borrowings and the current portion of long-term debt declined to $980.6 million from $1.21 billion, while long-term debt decreased to $1.06 billion from $1.07 billion. Combined debt reported in those two balance-sheet lines fell by approximately $247.1 million.

Inventory increased to $1.20 billion from $1.11 billion at year-end, an approximately 8% rise. Receivables also increased to $1.17 billion from $1.12 billion, alongside the company’s higher sales level.

Earnings guidance

AMETEK raised its full-year adjusted EPS range to $8.20-$8.30 from $7.94-$8.14. The low end increased by $0.26 and the high end by $0.16, reflecting management’s stronger outlook for the remainder of 2026. The company now expects full-year sales growth of approximately 10% compared with 2025.

Risks investors should monitor

• Acquisition execution and margin dilution: Recent acquisitions contributed to sales but reduced EIG’s reported adjusted margin relative to its core margin. Integration expenses could continue to create differences between GAAP and underlying operating measures.
• Higher financing costs: GAAP interest expense rose to $30.1 million from $16.9 million. Although part of the increase came from a one-time bridge financing fee, financing costs reduced the amount of operating profit reaching net income.
• International operating and cost exposure: AMETEK identified tariffs, trade disputes, foreign-exchange movements, supply-chain disruptions, and raw-material costs as uncertainties that could affect sales and margins.
• Guidance execution: The raised outlook calls for approximately 10% full-year sales growth and adjusted EPS of $8.20-$8.30, placing continued importance on organic demand, acquisition contributions, and conversion of the 28% order growth into revenue.

Summary

AMETEK’s Q2 2026 results combined 15% sales growth with faster adjusted profit and cash-flow expansion. EMG supplied the clearest margin improvement, while EIG maintained double-digit sales growth despite acquisition-related dilution. Strong order growth and free-cash-flow conversion supported the higher full-year outlook, with acquisition integration, financing costs, and the conversion of orders into sales remaining the main areas to monitor.